Patent · US Active

Methods for using anti-myostatin antibodies

US11439704B2 · kind B2 · utility

3Cited by
12References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2020
Grant dateSep 13, 2022
Priority date—
Expiry dateSep 23, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.